Ad
related to: ugur sahin
Search results
Cancer vaccine could be available before 2030, says scientist couple behind COVID-19 shot
Business Insider via Yahoo News· 2 years agoAn employee holds up a vial of an oncological product under development, at the BioNTech research...
Cancer vaccine could be available by 2030, say scientists behind Covid jab
Press Association News via AOL· 2 years agoCancer vaccines could be accessible to patients within the next decade, the husband and wife team...
BioNTech sees UK trials on cancer vaccines starting this year, paper says
Reuters via Yahoo News· 1 year agoClinical trials for BioNTech's cancer vaccines should start this year in Britain, marking an...
BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5...
Benzinga via Yahoo Finance· 11 months agoIn an annual general meeting, BioNTech SE's (NASDAQ: BNTX) CEO and co-founder Ugur Sahin told...
Q3 2023 BioNTech SE Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 months agoParticipants Jens H. Holstein; CFO & Member of Management Board; BioNTech SE Ozlem Tureci; Co-Founder, Chief Medical Officer & Member of Management Board; BioNTech SE Ryan Richardson; Chief ...
BioNTtech in conflict with regulator over new COVID vaccine approval - WAS
Reuters via Yahoo News· 2 years agoThe launch of German drugmaker BioNTech's vaccine adapted to the Omicron coronavirus variant may be...
BioNTech SE (NASDAQ:BNTX) stock most popular amongst private equity firms who own 44%, while...
Simply Wall St. via Yahoo Finance· 1 year agoA look at the shareholders of BioNTech SE (NASDAQ:BNTX) can tell us which group is most powerful....
BioNTech SE (NASDAQ:BNTX) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 9 months agoBioNTech SE (NASDAQ:BNTX) Q2 2023 Earnings Call Transcript August 7, 2023 Operator: Welcome to...
Individual investors own 21% of BioNTech SE (NASDAQ:BNTX) shares but private equity firms control...
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls BioNTech SE (NASDAQ:BNTX), then you'll have to look at the...
BioNTech Posts About 50% Drop In Q3 Sales and Profits Amid Falling Demand For COVID-19 Shots
Benzinga via Yahoo Finance· 1 year agoBioNTech SE (NASDAQ: BNTX) has reported Q3 FY22 revenues of €3.46 billion, down from €6.09 billion a...
